Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. 2014

A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
1] Inserm, UMR1048, Obesity Research Laboratory, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France [2] University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.

BACKGROUND It has been suggested that the metabolic benefits of physical exercise could be mediated by myokines. We examined here the effect of exercise training on skeletal muscle expression of a panel of myokines in humans. Pathways regulating myokine expression were investigated in human myotubes. METHODS Eleven obese non-diabetic male subjects were enrolled in an 8-week endurance training program. Insulin sensitivity was assessed by an oral glucose tolerance test. Subcutaneous adipose tissue and Vastus lateralis muscle biopsy samples were collected before and after training. RNAs were prepared from adipose tissue and skeletal muscle. Primary culture of myoblasts was established. RESULTS As expected, exercise training improved aerobic capacity and decreased fat mass. No significant change in interleukin 6, fibroblast growth factor 21, myostatin (MSTN) or irisin mRNA level was found in muscle after training. A twofold increase in apelin mRNA level was found in muscle but not in adipose tissue. No change in circulating myokine and adipokine plasma levels was observed in the resting state in response to training. Interestingly, apelin was significantly expressed and secreted in primary human myotubes. Apelin gene expression was upregulated by cyclic AMP and calcium, unlike the other myokines investigated. Importantly, changes in muscle apelin mRNA levels were positively related to whole-body insulin sensitivity improvement. CONCLUSIONS Collectively, our data show that exercise training upregulates muscle apelin expression in obese subjects. Apelin expression is induced by exercise signaling pathways and secreted in vitro in human primary myotubes, and may behave as a novel exercise-regulated myokine with autocrine/paracrine action.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010807 Physical Endurance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Endurance, Physical,Physical Stamina,Stamina, Physical
D005346 Fibroblast Growth Factors A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family. DNA Synthesis Factor,Fibroblast Growth Factor,Fibroblast Growth Regulatory Factor,Growth Factor, Fibroblast,Growth Factors, Fibroblast
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073861 Apelin A 77 amino acid secreted endogenous ligand for the angiotensin II receptor-like 1 protein (APELIN RECEPTOR) that is proteolytically cleaved into four smaller peptides: Apelin-36, Apelin-31, Apelin-28, and Apelin-13. It inhibits entry of HIV into cells that express both APJ and CD4 ANTIGEN and is highly expressed in breast milk, where it may modulate the neonatal immune response.
D000089703 Fibroblast Growth Factor-23 A specific fibrobroblast growth factor that is primarily synthesized by OSTEOCYTES and OSTEOBLASTS. It is involved in regulating phosphate homeostasis and renal phosphate excretion. Fibroblast Growth Factor 23
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
November 2009, Experimental physiology,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
August 2018, Cytokine,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
December 2014, International journal of sports medicine,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
November 2023, The Journal of clinical endocrinology and metabolism,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
July 2002, Acta physiologica Scandinavica,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
September 2013, Nutrition & diabetes,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
July 2003, Muscle & nerve,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
June 2019, Biochemical and biophysical research communications,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
June 2015, Journal of exercise nutrition & biochemistry,
A Besse-Patin, and E Montastier, and C Vinel, and I Castan-Laurell, and K Louche, and C Dray, and D Daviaud, and L Mir, and M-A Marques, and C Thalamas, and P Valet, and D Langin, and C Moro, and N Viguerie
September 2016, PLoS genetics,
Copied contents to your clipboard!